Free cash flow
Edwards Lifesciences Free cash flow decreased by 106.0% to -$21.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 109.4%, from $224.40M to -$21.10M. Over 3 years (FY 2021 to FY 2025), Free cash flow shows relatively stable performance with a -1.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests strong operational efficiency and the ability to self-fund future innovation or return capital to shareholders, while a decrease may indicate heavy capital expenditure cycles or declining operational profitability.
Detailed definition
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Peer comparison
High-growth semiconductor and AI infrastructure peers typically prioritize reinvestment, so free cash flow margins are often compared against R&D intensity and capital expenditure requirements of industry rivals.
free_cash_flowHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $456.80M | $471.20M | $283.80M | $220.60M | $289.10M | $250.00M | $213.90M | $252.60M | -$14.30M | $356.20M | $48.30M | -$118.80M | $286.10M | $299.90M | $224.40M | $240.90M | $516.20M | $353.50M | -$21.10M |
| QoQ Change | — | +3.2% | -39.8% | -22.3% | +31.1% | -13.5% | -14.4% | +18.1% | -105.7% | >999% | -86.4% | -346.0% | +340.8% | +4.8% | -25.2% | +7.4% | +114.3% | -31.5% | -106.0% |
| YoY Change | — | — | — | — | -36.7% | -46.9% | -24.6% | +14.5% | -104.9% | +42.5% | -77.4% | -147.0% | >999% | -15.8% | +288.9% | -15.8% | +72.1% | — | -109.4% |
Free cash flow at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's free cash flow?
- Edwards Lifesciences (EW) reported free cash flow of -$21.10M in Q1 2026.
- How has Edwards Lifesciences's free cash flow changed year-over-year?
- Edwards Lifesciences's free cash flow decreased by 109.4% year-over-year, from $224.40M to -$21.10M.
- What is the long-term trend for Edwards Lifesciences's free cash flow?
- Over 3 years (2021 to 2025), Edwards Lifesciences's free cash flow has grown at a -1.7% compound annual growth rate (CAGR), from $1.41B to $1.34B.
- What does free cash flow mean?
- The cash a company has left over after paying for its operating expenses and capital investments.